Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAT | NBTX | BBOT | ||
| Company | Phathom Pharmaceuticals Inc | Nanobiotix S.A. ADR | Bridgebio Oncology Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.20 | 22.55 | 12.40 | ||
| High | 14.64 | 23.38 | 13.27 | ||
| Low | 14.12 | 22.19 | 12.36 | ||
| Latest | 14.55 | 22.54 | 12.88 | ||
| Change | +0.34 | +1.27 | +0.35 | ||
| % Change | +2.39% | +5.97% | +2.79% | ||
| Volume | 671,300 | 98,900 | 148,100 | ||
| 20-Day Average Volume | 823,545 | 49,715 | 174,015 | ||
| Previous Close | 14.21 | 21.27 | 12.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 14.77 | 21.17 | 12.51 | ||
| 20-Day Raw Stochastic | 30.71% | 77.01% | 52.51% | ||
| 20-Day Relative Strength | 54.06 | 56.00 | 54.37 | ||
| Weighted Alpha | +31.82 | +499.47 | +25.69 | ||
| Today's Opinion | 80% Buy | 80% Buy | 96% Buy | ||
| Previous Opinion | 80% Buy | 56% Buy | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.82% since 12/03/25 | +7.18% since 12/03/25 | +16.35% since 12/03/25 | ||
| Low | 14.12 on 12/10/25 | 20.83 on 12/08/25 | 11.02 on 12/04/25 | ||
| High | 15.14 on 12/09/25 | 23.38 on 12/10/25 | 14.87 on 12/08/25 | ||
| 1-Month | |||||
| %Chg | +5.97% since 11/10/25 | +1.67% since 11/10/25 | +1.50% since 11/10/25 | ||
| Low | 13.79 on 11/12/25 | 19.14 on 11/26/25 | 10.68 on 12/03/25 | ||
| High | 16.26 on 11/28/25 | 23.56 on 11/17/25 | 14.87 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +18.10% since 09/10/25 | +141.07% since 09/10/25 | +28.16% since 09/10/25 | ||
| Low | 10.33 on 10/07/25 | 9.32 on 09/15/25 | 9.50 on 09/15/25 | ||
| High | 16.26 on 11/28/25 | 30.35 on 10/13/25 | 14.87 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +62.21% since 06/10/25 | +364.74% since 06/10/25 | +19.26% since 06/10/25 | ||
| Low | 7.61 on 07/22/25 | 4.18 on 06/18/25 | 8.50 on 08/05/25 | ||
| High | 16.26 on 11/28/25 | 30.35 on 10/13/25 | 14.87 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,010,871 | 1,019,748 | 1,002,262 | ||
| Shares Outstanding, K | 71,138 | 47,943 | 79,989 | ||
| Annual Sales | 55,250,000 | -7,780,000 | 0 | ||
| Annual Net Income | -334,330,000 | -73,730,000 | -74,275,000 | ||
| Last Quarter Sales | 49,500,000 | N/A | 0 | ||
| Last Quarter Net Income | -29,970,000 | N/A | -44,757,000 | ||
| 60-Month Beta | 0.43 | 0.71 | 0.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 10/30/25 | N/A | -1.03 on 11/12/25 | ||
| Latest Earnings Date | 03/05/26 | 01/01/70 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||